It's no Alibaba, but cancer drug developer Calithera boosts IPO
September 19, 2014 at 13:53 PM EDT
Cancer drug developer Calithera Biosciences Inc., one of the more promising Bay Area biotech companies in the IPO queue, upsized its offering target by nearly 30 percent to $103...